phone icon303-444-6950 | 301-913-0213
divider

News

separator

Marv Caruthers Inducted Into National Inventors Hall of Fame

You will be redirected to: http://www.invent.org/honor/inductees/inductee-detail/?IID=549
Read More
separator

Boulder’s bioscience industry growing to critical mass

You will be redirected to: https://bizwest.com/2018/04/18/boulders-bioscience-industry-growing-to-critical-mass/
Read More
separator

Zenoss Announces Partnership With Google Cloud

You will be redirected to: http://www.zenoss.com/company/newsroom/press-releases/zenoss-announces-partnership-google-cloud
Read More
separator

The AMGA's New Fourth Discipline

You will be redirected to: https://amga.com/amgas-new-fourth-discipline/
Read More
separator

ArcherDX Closes $35 Million Series A Financing

You will be redirected to: https://www.prnewswire.com/news-releases/archerdx-closes-35-million-series-a-financing-300616280.html
Read More
separator

miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

You will be redirected to: http://investors.miragen.com/file/Index?KeyFile=392600891
Read More
separator

Zenoss Announces Results for 2017

You will be redirected to: https://www.zenoss.com/company/newsroom/press-releases/zenoss-announces-results-2017
Read More
separator

miRagen Therapeutics, Inc. Prices Public Offering of Common Stock

You will be redirected to: http://investors.miragen.com/file/Index?KeyFile=392116919
Read More
separator

Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma in Phase 3 COLUMBUS Trial

You will be redirected to: http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2330521
Read More
separator


BV Serial Entrepreneur Manish Vachharajani explains the Meltdown vulnerability

Read More
separator